Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Cancer Res. 2010 Apr 13;70(9):3606–3617. doi: 10.1158/0008-5472.CAN-09-4598

Figure 4.

Figure 4

DNA binding activity of NF-κB in nuclear protein extracts of BxPC-3, MIAPaCa-E, and MIAPaCa-M cells as assessed by electrophoretic mobility shift assay. Cells were treated with 1 to 4 μmol/L CDF/curcumin, 10 nmol/L gemcitabine, or their combinations for 72 h.